Dr. Mikhail Blagosklonny is amongst the medical professionals who are on the forefront of battling cancer. A professor of Oncology at New York’s Roswell Park Cancer Institute, he is well known for his support of using the drug Rapamycin, also known as Sirolimus, to slow down the aging process. Rapamycin is also used to contain numerous conditions as Mikhail Blagosklonny has discovered through his various researches.
Uses of Rapamycin
Dr. Mikhail’s research on the use of Rapamycin has led him to discover various healing properties of the drug.
- Coronary Stent Coating. After a balloon angioplasty procedure, rapamycin can be applied to the arteries to prevent restenosis. Studies on patients who used the drug showed that very few of them complained of restenosis. Thus, they didn’t have a need to redo the procedure more often.
- Immunosuppressant. The body is designed to reject transplanted. Nonetheless, if that were to be allowed, operations would be unsuccessful. Doctors, therefore, use anti-rejection drugs. However, rapamycin has been found to be the best option as it has the least amounts of toxicity and other side effects to the organs.
- Used in cancer treatment. It has been established that when cancer patients take the right measures of Sirolimus, their immune systems get boosted. Eventually, it also prevents tumors from worsening. Use of the drug can also prevent new organs from getting the disease.
- Treating Tuberous Sclerosis Complex (TSC). Anyone with TSC congenital disorder is at risk of developing benign tumors in critical organs like the heart or even brain. In a study, use of rapamycin saw TSC get blocked. Stoppage of the medication resulted in the tumors growing again.
These are just but a few of the benefits of rapamycin as revealed by Dr. Mikhail Blagosklonny. He is still involved in current research about Sirolimus and how it can be used to extend human lifespan.
Dr. Blagosklonny’s Future Plans for Oncology
A renowned professor, researcher, and philanthropist, Mikhail Blagosklonny has a mission to ensure every individual has access to the best cancer treatment regardless of wealth status or location. He has nonetheless committed a better part of his research to both aging and cancer.Mikhail Blagosklonny is fixed on finding not only a cure for cancer, but he wants the experience of the treatment to be much better than it is now. Instead of the high costs and painful procedures, Mikhail hopes to find a cure that does not involve the destruction of other cells that are crucial to the recovery process. He also hopes that cancer treatment will be affordable for everyone, and not just for the high and mighty.
About Mikhail Blagosklonny
For school, Mikhail Blagosklonny went to St. Petersburg’s First Pavlov State Medical University, where he earned an MD in Internal Medicine, as well as a Ph.D. in Experimental Medicine and Cardiology. He had a role as Senior Scientist at Ordway Research Institute, before becoming Professor of Oncology at the Roswell Park Cancer Institute. He is also Editor-in-chief of Oncotarget and is on the journalist’s editorial board of Cell Death and Differentiation.